Drug class
Endothelin Receptor Antagonist; Phosphodiesterase 5 Inhibitor
Mechanism of action
Endothelin Receptor Antagonists [MoA]
General use cases
- Hypertension, Pulmonary
- pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risks of disease progression and hospitalization for PAH ( 1
- pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risks of disease progression and hospitalization for PAH
- pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risk of disease progression and hospitalization for PAH ( 1
- pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risks of disease progression and hospitalization for PAH (1
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
